Capital Advantage, Inc. Medtronic PLC Transaction History

Capital Advantage, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$118.19 - $131.5 $368,752 - $410,280	-3,120 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$111.18 - $119.74 $44,472 - $47,896	400 Added 14.71%	3,120 $369,000
Q4 2020 Feb 17, 2021	BUY	$100.57 - $117.14 $13,275 - $15,462	132 Added 5.1%	2,720 $318,000
Q3 2020 Nov 12, 2020	SELL	$90.13 - $108.78 $2,884 - $3,480	-32 Reduced 1.22%	2,588 $273,000
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $13,121 - $16,119	156 Added 6.33%	2,620 $240,000

Q1 2020 May 08, 2020	BUY	$72.92 - $121.3 $36,678 - $61,013	503 Added 25.65%	2,464 $255,000
Q4 2019 Feb 14, 2020	BUY	$104.49 - $114.54 $204,904 - $224,612	1,961 New	1,961 $234,000

2,237

1.05B

6.1M

7.84M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $103B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Capital Advantage, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital Advantage, Inc. with notifications on news.